Search
Descriptor English: Aspirin
Descriptor Spanish: Aspirina
Descriptor aspirina
Entry term(s) ácido acetilsalicílico
Scope note: Analgésico prototípico utilizado en el tratamiento del dolor de ligero a moderado. Tiene propiedades antiinflamatorias y antipiréticas y actúa como inhibidor de la ciclooxigenasa, lo que da lugar a la inhibición de la biosíntesis de prostaglandinas. La aspirina inhibe también la agregación plaquetaria y se utiliza en la prevención de la trombosis arterial y venosa. (Martindale, The Extra Pharmacopoeia, 30th ed, p5)
Descriptor Portuguese: Aspirina
Descriptor French: Acide acétylsalicylique
Entry term(s): 2-(Acetyloxy)benzoic Acid
Acetylsalicylic Acid
Acetysal
Acid, Acetylsalicylic
Acylpyrin
Aloxiprimum
Colfarit
Dispril
Easprin
Ecotrin
Endosprin
Magnecyl
Micristin
Polopirin
Polopiryna
Solprin
Solupsan
Zorprin
Tree number(s): D02.455.426.559.389.657.410.595.176
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D001241
Scope note: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anti-Inflammatory Agents, Non-Steroidal
Fibrinolytic Agents
Platelet Aggregation Inhibitors
Cyclooxygenase Inhibitors
Antipyretics
Registry Number: R16CO5Y76E
CAS Type 1 Name: Benzoic acid, 2-(acetyloxy)-
Public MeSH Note: 65; was ACETYLSALICYLIC ACID 1963-64
History Note: 65; was ACETYLSALICYLIC ACID 1963-64
DeCS ID: 27951
Unique ID: D001241
NLM Classification: QV 95
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1965/01/01
Date of Entry: 1999/01/01
Revision Date: 2013/07/08
Aspirin - Preferred
Concept UI M0001864
Scope note The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
Preferred term Aspirin
Entry term(s) 2-(Acetyloxy)benzoic Acid
Acetylsalicylic Acid
Acid, Acetylsalicylic
Acylpyrin - Narrower
Concept UI M0001871
Preferred term Acylpyrin
Aloxiprimum - Related but not broader or narrower
Concept UI M0001863
Preferred term Aloxiprimum
Colfarit - Narrower
Concept UI M0001872
Preferred term Colfarit
Dispril - Narrower
Concept UI M0351707
Preferred term Dispril
Easprin - Narrower
Concept UI M0001868
Preferred term Easprin
Ecotrin - Narrower
Concept UI M0001873
Preferred term Ecotrin
Endosprin - Narrower
Concept UI M0001874
Preferred term Endosprin
Magnecyl - Narrower
Concept UI M0001875
Preferred term Magnecyl
Micristin - Narrower
Concept UI M0001876
Preferred term Micristin
Polopirin - Related but not broader or narrower
Concept UI M0001866
Preferred term Polopirin
Polopiryna - Narrower
Concept UI M0001877
Preferred term Polopiryna
Solprin - Narrower
Concept UI M0001865
Preferred term Solprin
Solupsan - Related but not broader or narrower
Concept UI M0001867
Preferred term Solupsan
Zorprin - Narrower
Concept UI M0001869
Preferred term Zorprin
Acetysal - Narrower
Concept UI M0001870
Preferred term Acetysal



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey